NCT01982123View on ClinicalTrials.gov

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 17, 2014

Primary Completion Date

September 13, 2017

Study Completion Date

September 13, 2017

Conditions
Lung CarcinomaMalignant Neoplasm
Interventions
DIAGNOSTIC_TEST

SPECT/CT

Undergo 99mTc-MAA and 99mTc-DTPA SPECT/CT mid-radiation and post-radiation

PROCEDURE

Single Photon Emission Computed Tomography

Undergo 99mTc-MAA and 99mTc-DTPA SPECT/CT

RADIATION

Technetium Tc-99m Albumin Aggregated

Undergo 99mTc-MAA SPECT/CT

DRUG

Technetium Tc-99m DTPA

Undergo 99mTc-DTPA SPECT/CT

Trial Locations (2)

98109

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

98133

ProCure Proton Therapy Center-Seattle, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT01982123 - SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy | Biotech Hunter | Biotech Hunter